ED
Global Health EDCTP3 Joint Undertaking (EDCTP3)

Accelerating the Development of Prophylactic Vaccines Against Neglected Tropical Diseases (NTDs) in Sub-Saharan Africa

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

ClosedGlobal Health EDCTP3 Joint Undertaking (EDCTP3)EUAlbaniaArmeniaBosnia and HerzegovinaCanadaFaroe IslandsGeorgiaIcelandIsraelKosovoMoldovaMontenegroNew ZealandNorth MacedoniaNorwaySerbiaTunisiaTรผrkiyeUkraineUnited KingdomMoroccoSouth KoreaSwitzerlandBJBFCMCICDEthiopiaSZGAGMGhanaGWGNKenyaLRMWMLMZNENigeriaCGRwandaSenegalSLSOSouth AfricaTanzaniaUgandaZMZW

Full second-stage proposals are scored on the same three criteria used across other EDCTP3 topics: Excellence and Impact each need at least 4 out of 5, Quality and Efficiency of the Implementation needs at least 3 out of 5, and the combined score across all three must reach at least 12 out of 15 before a proposal is even considered for funding. Within that pool, the funding decision doesn't stop aโ€ฆ

This topic wants early- or late-stage clinical trials of prophylactic vaccines against a named list of 16 neglected tropical diseases in sub-Saharan Africa, from Buruli ulcer and dengue to schistosomiasis, leprosy and trachoma; Chagas disease, scabies and snakebite envenoming are explicitly out of scope, as is implementation research. It wants data generated across the general population and, where relevant, pregnant women, newborns, children and people with co-infections, with a clear regulatory and access strategy.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.โ‚ฌ45.9M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
European Commission logo
Scheduled

Clinical trials for advancing innovative interventions for neurodegenerative diseases

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

MedtechBiotech
โ‚ฌ10MApr'27
Department for Science, Innovation and Technology logo
Open

Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

๐Ÿ‡ฌ๐Ÿ‡งDSIT ยท United Kingdom

Capital grants for large-scale UK life sciences R&D investments.

BiotechMedtech+1
ยฃ5M โ€“ ยฃ25MApr'28
European Commission logo
Scheduled

Innovative Antimicrobials Against Resistant Pathogens

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.

BiotechMedtech
โ‚ฌ8M โ€“ โ‚ฌ10MApr'27
Ministero delle Imprese e del Made in Italy logo
Open

STEP / Critical and Emerging Technologies โ€” 14 (Tecnologie Critiche ed Emergenti)

๐Ÿ‡ฎ๐Ÿ‡นMIMIT ยท Italy

Funds Italian companies in southern regions to develop critical innovation in climate, health, and materials.

AIClimate Tech+6
โ‚ฌ1M โ€“ โ‚ฌ20M
European Commission logo
Scheduled

Personalised approaches to reduce risks from adverse drug reactions due to multiple medications

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds safer medication management using biomarkers, clinical data and decision support.

MedtechBiotech+1
โ‚ฌ8M โ€“ โ‚ฌ10MApr'27
European Commission logo
Scheduled

Horizon Health: Antibody Therapies for Emerging Viruses

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds โ‚ฌ9โ€“10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.

BiotechMedtech
โ‚ฌ9M โ€“ โ‚ฌ10MApr'27